Zura Bio Ltd has a consensus price target of $18.57 based on the ratings of 8 analysts. The high is $26 issued by Piper Sandler on May 3, 2024. The low is $10 issued by Ladenburg Thalmann on October 10, 2023. The 3 most-recent analyst ratings were released by Oppenheimer, Piper Sandler, and Oppenheimer on May 10, 2024, May 3, 2024, and April 1, 2024, respectively. With an average price target of $21 between Oppenheimer, Piper Sandler, and Oppenheimer, there's an implied 452.63% upside for Zura Bio Ltd from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
06/17/2024 | Buy Now | — | Cantor Fitzgerald | Josh Schimmer | — | Reiterates | → Overweight | Get Alert |
06/12/2024 | Buy Now | — | Cantor Fitzgerald | Josh Schimmer | — | Initiates | → Overweight | Get Alert |
05/10/2024 | Buy Now | 452.63% | Oppenheimer | Jeff Jones | $16 → $21 | Maintains | Outperform | Get Alert |
05/03/2024 | Buy Now | 584.21% | Piper Sandler | Yasmeen Rahimi | → $26 | Initiates | → Overweight | Get Alert |
04/01/2024 | Buy Now | 321.05% | Oppenheimer | Jeff Jones | $17 → $16 | Reiterates | Outperform → Outperform | Get Alert |
10/10/2023 | Buy Now | 163.16% | Ladenburg Thalmann | Aydin Huseynov | → $10 | Initiates | → Buy | Get Alert |
08/25/2023 | Buy Now | 347.37% | Oppenheimer | Justin Kim | → $17 | Initiates | → Outperform | Get Alert |
08/15/2023 | Buy Now | 478.95% | Raymond James | Steven Seedhouse | $20 → $22 | Maintains | Strong Buy | Get Alert |
06/22/2023 | Buy Now | 426.32% | Guggenheim | Yatin Suneja | → $20 | Initiates | → Buy | Get Alert |
06/14/2023 | Buy Now | 268.42% | Chardan Capital | Matthew Barcus | → $14 | Initiates | → Buy | Get Alert |
05/24/2023 | Buy Now | 426.32% | Raymond James | Steven Seedhouse | → $20 | Initiates | → Strong Buy | Get Alert |
The latest price target for Zura Bio (NASDAQ:ZURA) was reported by Cantor Fitzgerald on June 17, 2024. The analyst firm set a price target for $0.00 expecting ZURA to fall to within 12 months (a possible -100.00% downside). 8 analyst firms have reported ratings in the last year.
The latest analyst rating for Zura Bio (NASDAQ:ZURA) was provided by Cantor Fitzgerald, and Zura Bio reiterated their overweight rating.
There is no last upgrade for Zura Bio
There is no last downgrade for Zura Bio.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Zura Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Zura Bio was filed on June 17, 2024 so you should expect the next rating to be made available sometime around June 17, 2025.
While ratings are subjective and will change, the latest Zura Bio (ZURA) rating was a reiterated with a price target of $0.00 to $0.00. The current price Zura Bio (ZURA) is trading at is $3.80, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.